Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan
3d ago
TAK
NVAX
Premium
The Fly
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
4d ago
CRM
NOW
Premium
The Fly
Alkermes initiated with an Overweight at Wells Fargo
4d ago
TAK
ALKS
Premium
The Fly
Takeda’s FRUZAQLA reimbursed in Quebec for treatment of mCRC
10d ago
TAK
Premium
The Fly
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
16d ago
TAK
IONS
Premium
Company Announcements
Takeda’s Narcolepsy Drug Study Abstract Accidentally Published
1M ago
Premium
Company Announcements
Takeda Pharmaceutical Reports Q1 2025 Earnings with Profit Growth
1M ago
Premium
The Fly
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year
1M ago
TAK
Premium
The Fly
Takeda backs FY25 core EPS view 485 yen
1M ago
TAK
Premium
Company Announcements
Takeda Pharmaceutical Reports Mixed Financial Results for Q2 2025
1M ago
Premium
The Fly
Alkermes selling off on limited data disclosure, says BofA
2M ago
TAK
ALKS
Premium
The Fly
Takeda receives FDA clearance for HyHub, HyHub Duo
2M ago
TAK
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
2M ago
BMY
NVO
Premium
The Fly
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
2M ago
TAK
KROS
Premium
Ratings
Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of Oveporexton
2M ago
TAK
Premium
The Fly
Morning Movers: Sonnet BioTherapeutics skyrockets after $888M combination
2M ago
AZN
TAK
Premium
The Fly
Takeda announces oveporexton studies met all primary, secondary endpoints
2M ago
TAK
Premium
Company Announcements
Takeda’s Oveporexton Shows Promise in Phase 3 Narcolepsy Studies
2M ago
Premium
Company Announcements
Takeda Completes Treasury Share Disposal with Minor Adjustments
2M ago
Premium
The Fly
Takeda announces FDA approval of Gammagard Liquid ERC
2M ago
TAK
Premium
Company Announcements
Takeda Announces New Director Assignments, Emphasizing Strong Governance
2M ago
Premium
Company Announcements
Takeda Announces Disposal of Treasury Shares for Global Employee Incentive Plan
3M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
